Horizon2020 Work Programmes for 2018-2020
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. The new Work Programmes for 2018-2020 are now published.
Horizon 2020 is the financial instrument of the European Commission that aims to drive economic growth and create jobs. Within Horizon 2020, research and innovation are coupled with an emphasis on excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.
Horizon 2020 is open to everyone
Funding opportunities under Horizon 2020 are set out in multiannual work programmes, which cover the large majority of support available. The current main Horizon 2020 work programme comprises an introduction,17 thematic sections and the general annexes describing general rules such as standard admissibility conditions and eligibility criteria, selection and award criteria, etc. Two of the thematic sections that are specifically relevant for research on antimicrobial resistance and /or infectious diseases and are explained below:
Health, demographic change and wellbeing
Building on the principle of openness – open science, open innovation and open to the world the societal challenge on ‘health, demographic change and well-being’ aims to deliver solutions for a better health for all by:
- Moving towards the effective integration of personalised medicine approaches into healthcare services and systems to the benefit of patients and citizens;
- Fighting infectious diseases and the growing threat of antimicrobial resistance;
- Addressing the needs of the most vulnerable groups and the global increase of chronic diseases;
- Decoding the role of environment – including climate change and air quality – on health and developing mitigating measures;
- Exploring the digital potential for health innovation and healthcare, including the building of a ‘European health research and innovation cloud’;
- Stimulating innovation in the European healthcare domain and industry by exploring the application of advanced technologies, improve the health of the workforce and promote regulatory science
Click on the link for more information on this ‘Health’ work programme.
Food security, sustainable agriculture and forestry, marine, maritime and inland water research and the bioeconomy
The Sustainable Food Security call advocates for food system approaches to tackle the inherent links between ecosystems, food production, the food chain and consumer health and wellbeing. The SFS call aims to:
- deliver diverse and healthy food from land and sea;
- increase resource efficiency and environmental performance of food systems from primary production to consumers;
- understand the impact of climate change on agriculture, resources, food quality and identify options to manage its effects;
- reduce greenhouse gas emissions and emissions of air pollutants from land use and food production taking into account main drivers such as inputs and consumption patterns
Click on the link for more information on this ‘Food security’ work programme.
The NADP can support you in finding project partners for projects aimed at the development of new antibiotics and alternative therapies (prevention and care) for human and animal health. You can contact the NADP Alliance Manager Schelto Korf via [email protected] with your questions about matchmaking and opportunities for your own project.
NWO TTW Perspectief round 2017/2018
The new NWO TTW Perspectief round for 2017/2018 will open on 2 October 2017. The guidelines for the new round of Perspectief will be similar to the 2016/2017 guidelines.
- NWO-TTW will open the Perspectief 2017/2018 for all 9 Topsectors – Life Sciences & Health, Agri&Food, Chemistry, High Tech Systems & Materials, Creative Industry, Energy, Horticulture & starting materials, Logistics and Water.
- The minimum contribution from NWO-TTW for the program budget is 1,5 million Euros. The maximum contribution from NWO-TTW is 4 million Euros.
- The co-financing demand for users is the same as in 2016/2017. The co-financing will need to be for the entire program and not on a project level. The program co-financing should consist of a cash contribution of at least 15% of the total budget. Next to this a contribution of 30% of the total program budget should consist of co-financing by users in cash and or in kind contribution.
- NWO-TTW offers project partners the option to agree on their own terms for IP distribution.
The Perspectief procedure has three phases:
- Phase 1: Announcement project initiative
Deadline: 2 November, 14:00 hrs
- Phase 2: Project design
Deadline: 7 December 2017, 14:00 hrs
- Phase 3: Final project proposal
Deadline: 14 May 2018, 14:00 hrs
Read more at http://www.stw.nl/nl/perspectief
JPI AMR is preparing for 2 upcoming calls that will be announced in January 2018. Please check their website for latest information: https://www.jpiamr.eu/activities/joint-calls/
Partnering with AMR Centre (United Kingdom)
The AMR Centre’s mission is to accelerate the development of new antimicrobial drugs and diagnostics. As such the AMR Centre works globally with companies and research institutions to support the development of their products from lead optimization through to proof of concept and beyond. The AMR Centre aims to progress circa 5 new projects each year. Read more at http://www.amrcentre.com/partnering/
NADP will engage with EU and global initiatives in order to achieve synergies and focus on strategic priorities These include among others :
- A new EU strategy on AMR, plus the ongoing work under the IMI Innovative Medicines Initiative
- G7/G20 initiative on combatting AMR
- World Economic Forum: “Antibiotic resistance is the next great global challenge – we must act now”
- The creation of CARB-X was prioritized in the 2015 US National Action Plan on Combating Antibiotic-Resistant Bacteria (CARB), which called for a biopharmaceutical accelerator to spur pre-clinical product development.
- The Global Antibiotic Research and Development Partnership (GARDP) was established in May 2016 as a joint initiative by the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi).
- WHO Global action plan on AMR, including prioritisation of pathogens
- WHO review of the antibiotics chapter of the WHO Essential Medicines list